IMS 2022 | Limitations of prognostic staging systems for multiple myeloma
Moritz Binder
• 26 Aug 2022
Moritz Binder, MD, MPH, Mayo Clinic, Rochester, MN, talks on currently used prognostic staging systems in multiple myeloma, highlighting their limitations and the need for a more robust staging system to achieve individualized risk prediction and risk-adapted therapy. This interview took place at the 19th International Myeloma Society Meeting (IMS) held in Los Angeles, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
